| Name | Title | Contact Details |
|---|---|---|
Matthew Costner |
Chief People Officer | Profile |
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Businesses are finding themselves faced with transformative change, from cloud technology to big data. No better example than the life sciences industry which is transforming from a data-driven clinical enterprise to an information-driven one. As the EDC specialists OmniComm understands the power that an information-driven clinical enterprise can bring to your clinical research organization. OmniComm is the only company that provides our clients with a choice of best-of-breed EDC platforms that are purpose-built for their unique clinical research environments – Early Phase, Late Phase, Phase I-IV, device trials, Investigator Initiated. We bring the most advanced open and interoperable EDC platforms to our clients; through our innovative cloud technology and advanced API web services we provide our clients with information to make insight driven clinical data-based critical decisions, bringing medical therapies to patients faster with lower risk. OmniComm provides comprehensive solutions for clinical research with an extensive global experience from over 4,800 clinical trials. 4 of the 5 top CROs and 7 of the 10 largest Phase I Clinics run OmniComm EDC technologies.
Nue is a software development company that provides a revenue operations (RevOps) platform designed to meet the needs of modern businesses. The platform allows for easy management of omni-channel sales, dynamic customer journeys, and innovative pricing...
Community IT Innovators is a Washington, D.C. based IT consultancy providing technical staff and strategic technology support to nonprofit organizations.